Dipeptidyl peptidase-4 enzyme inhibition and its impacts on hepatic preneoplasia: a new avenue for liver cancer management.

Saved in:
Bibliographic Details
Title: Dipeptidyl peptidase-4 enzyme inhibition and its impacts on hepatic preneoplasia: a new avenue for liver cancer management.
Authors: Eitah HE; Medicinal and Pharmaceutical Chemistry Department, (Pharmacology Group), National Research Centre, Giza, Egypt., Sayed RH; Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.; School of Pharmacy, Newgiza University, Giza, Egypt., Maklad YA; Medicinal and Pharmaceutical Chemistry Department, (Pharmacology Group), National Research Centre, Giza, Egypt., Gamal El Din AA; Pharmacognosy Department, National Research Centre, Giza, Egypt., Mahmoud K; Pathology Department, National Research Centre, Giza, Egypt., El-Sahar AE; Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt., Alhejely A; Department of Biology, Darb University College, Jazan University, Jazan, Saudi Arabia., Abdulbaqi AA; Department of Biology, Darb University College, Jazan University, Jazan, Saudi Arabia., Naeim Attia H; Medicinal and Pharmaceutical Chemistry Department, (Pharmacology Group), National Research Centre, Giza, Egypt.
Source: Frontiers in pharmacology [Front Pharmacol] 2025 Jul 25; Vol. 16, pp. 1559303. Date of Electronic Publication: 2025 Jul 25 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1663-9812
DOI:10.3389/fphar.2025.1559303